Commentary by UAMS’ van Rhee Featured in Blood Journal
Frits van Rhee, clinical director of the UAMS Myeloma Center, weighed in on a new combination therapy for treating newly diagnosed Castleman disease patients in the April 18 issue of Blood, a publication by the American Society of Hematology. In the commentary, “Storming the Castle with TCP,” van Rhee and coauthor Katie Stone, then-director of…